Article (Scientific journals)
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ruggeri, Annalisa; Galimard, Jacques-Emmanuel; Labopin, Myriam et al.
2022In Transplantation and Cellular Therapy, 28 (10), p. 710.e1-710.e10
Peer Reviewed verified by ORBi
 

Files


Full Text
1-s2.0-S266663672201466X-main.pdf
Author postprint (749.66 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antilymphocyte Serum; 3A189DH42V (Alemtuzumab); 8N3DW7272P (Cyclophosphamide); Acute Disease; Adult; Alemtuzumab; Bone Marrow; Cyclophosphamide/therapeutic use; Fetal Blood; Graft vs Host Disease/prevention & control; Humans; Leukemia, Myeloid, Acute/therapy; Peripheral Blood Stem Cell Transplantation; Recurrence; Acute myelogenous leukemia; Double cord blood transplantation; Haploidentical transplant; Post-transplantation cyclophosphamide
Abstract :
[en] Unmanipulated haploidentical hematopoietic stem cell transplantation (HCT) with post-transplantation cyclophosphamide as graft-versus-host disease (GVHD) prophylaxis (haplo-PTCY) and unrelated double-unit umbilical cord blood transplantation (dUCBT) are feasible options for treating patients with high-risk acute myelogenous leukemia (AML). This study compared outcomes after dUCBT and haplo-HCT using peripheral blood stem cells (PBSCs) in adult patients with AML in complete remission (CR) who underwent transplantation in European Society for Blood and Marrow Transplantation (EBMT)-affiliated centers. In a population of adults with de novo AML in first or second CR, we compared outcomes after dUCBT (n = 165) and after haplo-PTCY PBSC (n = 544) performed between January 2013 and December 2018. Patients receiving in vivo antithymocyte globulin, Campath, or ex vivo T cell depletion were excluded. The median follow-up was 33 months for the haplo-PTCY arm and 52 months for the dUCBT arm. No statistically significant differences were observed between the 2 arms in the rates of grade II-IV acute graft-versus-host disease (GVHD) (hazard ratio [HR], 1.31; P = .18), grade III-IV acute GVHD (HR, 1.17; P = .56), chronic GVHD (HR, .86; P = .48), relapse (HR, 1.07; P = .77), nonrelapse mortality (NRM) (HR, .94; P = .77), leukemia-free survival (LFS) (HR, .99; P = .95), or overall survival (OS) (HR, .99; P = .97). Favorable cytogenetic risk was the sole factor predictive of lower relapse incidence (RI). Younger age at transplantation was associated with lower NRM and higher LFS and OS. Both dUCBT and haplo-PTCY with PBSCs can be considered valid approaches for adult AML patients in CR. New strategies should be investigated in both settings to define the most appropriate conditioning regimen and potentially decrease RI and NRM through better immune reconstitution and optimal supportive care.
Disciplines :
Hematology
Author, co-author :
Ruggeri, Annalisa;  Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy,
Galimard, Jacques-Emmanuel;  Hematology and Cellular Therapy Service, Hôpital Saint Antoine, AP-HP, Paris,
Labopin, Myriam;  Hematology and Cellular Therapy Service, Hôpital Saint Antoine, AP-HP, Paris,
Rafii, Hanadi;  Eurocord, Hôpital Saint Louis and IUH University Paris VII, Paris, France.
Blaise, Didier;  Institut Paoli Calmettes, Marseille, France.
Ciceri, Fabio;  Hematology and BMT Unit, San Raffaele Scientific Institute, Milano, Italy.
Diez-Martin, Jose-Luiz;  Hematology Department, Hospital GU Gregorio Marañon, Instituto de Investigación
Cornelissen, Jan;  Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the
Chevallier, Patrice;  Hematology Service, Hôtel Dieu, Nantes, France.
Sanchez-Guijo, Fermin;  Hematology Department, University Hospital of Salamanca, USAL-IBSAL, Salamanca,
Nicholson, Emma;  Department of Haematology, Royal Marsden Hospital, London, United Kingdom.
Castagna, Luca;  Humanitas Cancer Center, Rozzano, Italy.
Forcade, Edouard;  CHU Bordeaux, Hôpital Haut-leveque, Bordeaux, France.
Kuball, Jürgen;  Department of Hematology,University Medical Centre, Utrecht, the Netherlands.
Rovira, Montserrat;  BMT Unit, Department of Hematology, Institute of Hematology & Oncology, Hospital
Koc, Yener;  Medicana International, Istanbul, Turkey.
Pavlu, Jiri;  Department of Haematology, Hammersmith Hospital, Imperial College, London, United
Gulbas, Zafar;  Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Turkey.
Vydra, Jan;  Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
Baron, Frédéric  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Sanz, Jaime;  Hospital Universitario y Politécnico La Fe, Valencia, Spain and CIBERONC, Madrid,
Spyridonidis, Alexandros;  University Hospital of Patras, Patras, Greece.
Savani, Bipin;  Vanderbilt University Medical Center, Nashville, Tennessee.
Gluckman, Eliane;  Eurocord, Hôpital Saint Louis and IUH University Paris VII, Paris, France,
Nagler, Arnon;  Hematology Division, Chaim Sheba Medical Center, Tel Aviv University, Ramat Gan,
Mohty, Mohamad;  Hematology and Cellular Therapy Service, Hôpital Saint Antoine, AP-HP, Paris,
More authors (16 more) Less
Language :
English
Title :
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Publication date :
October 2022
Journal title :
Transplantation and Cellular Therapy
ISSN :
2666-6375
eISSN :
2666-6367
Publisher :
Elsevier, New York, Us ny
Volume :
28
Issue :
10
Pages :
710.e1-710.e10
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright © 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Available on ORBi :
since 29 December 2022

Statistics


Number of views
49 (3 by ULiège)
Number of downloads
2 (2 by ULiège)

Scopus citations®
 
4
Scopus citations®
without self-citations
3
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBi